Moreover, ADAR1 edits the nearby ORF stop codon of METTL3 mRNA, leading to its binding site changing to miR-532-5p and resulting in increased METTL3 protein, which further targets ARHGAP5 to promote breast cancer progression in a YTHDF1-dependent manner. Here, METTL3 is linked to breast carcinoma.